Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

Concern over ACA ruling grows as appeal on pause

Many Americans with disabilities and pre-existing conditions are concerned about their future if a ruling that overturns the Affordable Care Act remains in place.

Thumbnail

Doctor perspective: Climate change is a health emergency

Climate change impacts, from more harmful pollution to wildfire injuries, are negatively influencing human life. But doctors can help, according to two physicians who wrote a perspective in the New England Journal of Medicine.

Thumbnail

Arizona’s Medicaid work requirements approved

Arizona is the latest state to have approval for a Medicaid work requirement program—joining seven other states with approved programs.

Thumbnail

CVS and Walmart come to agreement after drug pricing battle

CVS Health and Walmart have reached a new, multiyear deal to continue their pharmacy business relationship. CVS announced the agreement Jan. 18, three days after the companies stated they would no longer be in the same network for filling prescription drugs after a pricing dispute.

Thumbnail

CMS introduces new models to lower drug prices in Part D, Medicare Advantage

CMS’ Center for Medicare and Medicaid Innovation (CMMI) has announced a new model that aims to lower prescription drug prices in Medicare Part D and introduced several updates to Medicare Advantage (MA) plans.

Thumbnail

CMS proposes 2020 payment notice

The Trump administration’s CMS has proposed a number of changes to the 2020 coverage year, including making changes to the individual health insurance exchange and qualified health plan provisions.

Thumbnail

Healthcare is the hottest stock sector

The healthcare sector remains a sweet spot for the stock market, ranked the most favored sector on the S&P 500 among Wall Street research firms, Reuters reported.

Thumbnail

Congress to look into drug prices

Rising drug prices have caught the attention of the Congressional Committee on Oversight and Reform, which announced it will open a “sweeping” drug price investigation.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”